In early-stage startups, we see the highest percentage of funding at 94.3%.
Singapore's startup funding rose by 46.72% sequentially to $80.4m in March, according to Tracxn.
Year-over-year, funding dropped by 81.24%.
In March, early-stage startups (94.3%) accounted for the majority of the funding, with seed-stage ventures trailing behind at 5.7%.
Chitose Bio Evolution ($49m), AMP ($12.6m), RockFlow ($10m), Agros ($4.3m), and MitoHealth ($2.2m) were the top deals for the month.
In March, Iterative led the venture capital funding, also emerging as the top incubator.
